Garnero, Patrick <br/><br/>
Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.  [electronic resource] 

 -  Arthritis and rheumatism  Jan 2002 
 - 21-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amino Acids--urine<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Biomarkers<br/>C-Reactive Protein--metabolism<br/>Collagen Type II--urine<br/>Cross-Linking Reagents--metabolism<br/>Etanercept<br/>Female<br/>Galactosides--urine<br/>Glucose--metabolism<br/>Glycosuria<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Joints--metabolism<br/>Male<br/>Matrix Metalloproteinase 3--blood<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Peptide Fragments--urine<br/>Prospective Studies<br/>Receptors, Tumor Necrosis Factor--administration & dosage